Livestock Healthcare Market Report 2025

The livestock healthcare market size has grown strongly in recent years. It will grow from $54.45 billion in 2024 to $58.54 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing livestock population, intensification of livestock farming, rising demand for animal products, globalization of the livestock industry, government initiatives for livestock health.

The livestock healthcare market size is expected to see rapid growth in the next few years. It will grow to $87.47 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to evolving disease landscape, focus on antibiotic reduction, growing awareness of zoonotic diseases, adoption of precision livestock farming, sustainable livestock practices. Major trends in the forecast period include biosecurity measures for disease prevention, genetic selection for disease resistance, remote consultation and veterinary services, focus on animal welfare and stress reduction, emergence of personalized medicine for livestock.

The rising incidence of food-borne and zoonotic diseases is anticipated to drive growth in the livestock healthcare market in the future. Foodborne diseases are infectious conditions resulting from the ingestion of food or water contaminated by pathogenic microorganisms, including bacteria, parasites, and viruses. Zoonotic diseases are illnesses that can be transmitted between animals and humans. Livestock healthcare is essential for detecting, preventing, and treating diseases in animals through vaccines and medications, thus, the growing prevalence of food-borne and zoonotic diseases is increasing the demand for livestock healthcare products. For instance, in December 2023, the European Food Safety Authority, an Italy-based public agency, reported that the European Union experienced 5,763 foodborne outbreaks in 2022, representing a 44% increase from the previous year. Therefore, the rising incidence of food-borne and zoonotic diseases is a significant driver of the livestock healthcare market.

The expanding livestock population is expected to further boost the growth of the livestock healthcare market. The livestock population refers to the total number of domesticated animals raised by humans for various purposes, including food, fiber, labor, and other products. This growing population necessitates livestock healthcare to ensure economic stability, guarantee food security, support farmers' livelihoods, promote sustainable agricultural practices, and control the spread of diseases. For example, in March 2024, the Department for Environment, Food, and Rural Affairs, a UK-based ministerial department, reported that the number of hens and pullets laying eggs for consumption increased from 40.44 million in 2022 to 41.07 million in 2023, while the breeding flock grew from 52.46 million to 53.79 million during the same timeframe. Therefore, the increasing livestock population is driving growth in the livestock healthcare market.

Technological innovations are a key trend gaining popularity in the livestock healthcare market. Major companies operating in the livestock healthcare market are focused on developing new technological solutions to strengthen their market position. For instance, in July 2022, Merck Animal Health, a US-based biopharmaceutical company that develops and produces medicines and vaccines, launched Whisper on Arrival, a first-of-its-kind technology that transforms decision-making for cattle. It is uniquely designed with specialized sound-gathering equipment and a predictive algorithm that helps to analyze animal breathing, heartbeat, weight, and rectal temperature and offers useful information to feedlot managers and vets for decisions involving specific animals. It aids in formulating a plan of action for the management of bovine respiratory disease (BRD) and identifies the cattle that may be more susceptible to illness.

Major companies operating in the livestock healthcare market are focused on introducing advanced solutions, such as ayurvedic formulations, to gain a competitive edge in the market. Ayurvedic formulations are traditional herbal preparations and remedies used in Ayurveda, a system of medicine with historical roots based on plants, animals extract, and minerals. For instance, in September 2023, Milma, an India-based dairy company launched ethno-veterinary medicines. Ethno-veterinary medicines are medicines made from Ayurvedic formulations and are designed to treat animal diseases. Ethno-veterinary medicines are used as low-cost alternatives to allopathic veterinary drugs. This medicines lessen the burden of veterinary expenses on farmers and provide a cost-effective solution for animal healthcare. This medicines are a simple, cost-effective, farmer-friendly tool that are used as preventives and curatives.

In September 2022, Zoetis Inc., a US-based producer of medicine and vaccinations for pets and livestock, acquired Jurox Animal Health for an undisclosed amount. Through this acquisition, combined resources with Jurox are expected to increase the range of products offered and the potential for global expansion for Zoetis. Jurox Animal Health is an Australian-based developer and producer of veterinary pharmaceutical solutions for livestock producers, veterinarians, and pet owners.

Major companies operating in the livestock healthcare market include Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Alltech Inc., Virbac SA, Ceva Santé Animale, Phibro Animal Health Corporation, Avivagen Inc., Dechra Pharmaceuticals plc, Huvepharma AD, Vetoquinol SA, Laboratorios Hipra S.A., Anpario plc, Kemin Industries Inc., Norbrook Laboratories Ltd., Alivira Animal Health Limited, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Hester Biosciences Limited, Vets Plus Inc., Phytobiotics Futterzusatzstoffe GmbH, Delacon Biotechnik GmbH, Bimeda Holdings plc, Inovet (V.M.D. NV/sa)

North America was the largest region in the livestock healthcare market in 2024. The regions covered in the livestock healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the livestock healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Livestock healthcare refers to the development of health-building and illness prevention, detection, and management strategies that support the health and welfare of farm animals. They are used for improving the health, welfare, and productivity of livestock.

The main types of livestock healthcare are vaccines, pharmaceuticals, feed additives, diagnostics, and other types. Feed additives are single ingredients or substances used in animal nutrition to improve the quality of feed and animal-derived foods. It contributes to the health and performance of the animals. These are applied to various livestock animals such as poultry, swine, cattle, sheep and goats, horses, and others and are used by various end users such as reference laboratories, point-of-care testing or in-house testing, veterinary hospitals and clinics, and others.

The livestock healthcare market research report is one of a series of new reports that provides livestock healthcare market statistics, including livestock healthcare industry global market size, regional shares, competitors with a livestock healthcare market share, detailed livestock healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the livestock healthcare industry. This livestock healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The livestock healthcare market consists of sales of livestock medications such as biologics and tick medications as well as tools for livestock disease diagnosis. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.